Electronic Resource

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis

التفاصيل البيبلوغرافية
العنوان: Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
المؤلفون: Piccoli, Luca, Campo, Ilaria, Fregni, Chiara Silacci, Fernandez Rodriguez, Blanca Maria, Minola, Andrea, Sallusto, Federica, Luisetti, Maurizio, Corti, Davide, Lanzavecchia, Antonio
بيانات النشر: 2019-07-31T06:25:32Z
نوع الوثيقة: Electronic Resource
مستخلص: Pulmonary alveolar proteinosis (PAP) is a severe autoimmune disease caused by autoantibodies that neutralize GM-CSF resulting in impaired function of alveolar macrophages. In this study, we characterize 21 GM-CSF autoantibodies from PAP patients and find that somatic mutations critically determine their specificity for the self-antigen. Individual antibodies only partially neutralize GM-CSF activity using an in vitro bioassay, depending on the experimental conditions, while, when injected in mice together with human GM- CSF, they lead to the accumulation of a large pool of circulating GM-CSF that remains partially bioavailable. In contrast, a combination of three non-cross-competing antibodies completely neutralizes GM-CSF activity in vitro by sequestering the cytokine in high-molecular-weight complexes, and in vivo promotes the rapid degradation of GM-CSF-containing immune complexes in an Fc-dependent manner. Taken together, these findings provide a plausible explanation for the severe phenotype of PAP patients and for the safety of treatments based on single anti-GM-CSF monoclonal antibodies.
URL: http://doc.rero.ch/record/326869/files/Piccoli_NC_2015.pdf
الاتاحة: Open access content. Open access content
ملاحظة: English
Other Numbers: CHRRO oai:doc.rero.ch:20190730104929-WI
1156712908
المصدر المساهم: RERO-LIBR NETWORK OF WESTERN SWITZERLAND
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1156712908
قاعدة البيانات: OAIster